Published in Clin Chim Acta on August 31, 1995
Platelets, a reliable source for peripheral Alzheimer's disease biomarkers? Acta Neuropathol Commun (2014) 0.82
Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A (2006) 19.60
A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke (2001) 5.81
Expression of human immunodeficiency virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet (1986) 4.54
Atrophy of medial temporal lobes on MRI in "probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry (1992) 4.16
Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain (1997) 3.87
Graph theoretical analysis of magnetoencephalographic functional connectivity in Alzheimer's disease. Brain (2008) 3.36
Global and local gray matter loss in mild cognitive impairment and Alzheimer's disease. Neuroimage (2004) 3.25
Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol (1999) 2.92
Incident lacunes influence cognitive decline: the LADIS study. Neurology (2011) 2.81
Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56
Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol (2007) 2.47
Detection by polymerase chain reaction of Treponema pallidum DNA in cerebrospinal fluid from neurosyphilis patients before and after antibiotic treatment. J Clin Microbiol (1991) 2.43
Association of gait and balance disorders with age-related white matter changes: the LADIS study. Neurology (2008) 2.41
Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry (2002) 2.41
Prevalence and severity of microbleeds in a memory clinic setting. Neurology (2006) 2.29
EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol (2010) 2.21
Histopathologic correlate of hypointense lesions on T1-weighted spin-echo MRI in multiple sclerosis. Neurology (1998) 2.17
[Prion disease: a new class of neurodegenerative disorders]. Ned Tijdschr Geneeskd (1995) 2.02
Ventilator setting in ICUs: comparing a Dutch with a European cohort. Neth J Med (2014) 2.02
Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry (2000) 1.97
Diagnosis and management of Alzheimer's disease and other disorders associated with dementia. The role of neurologists in Europe. European Federation of Neurological Societies. Eur J Neurol (2000) 1.89
Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures. Neurology (2009) 1.88
Histopathologic correlates of white matter changes on MRI in Alzheimer's disease and normal aging. Neurology (1995) 1.86
Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology. Brain (2008) 1.84
CT and MRI rating of white matter lesions. Cerebrovasc Dis (2002) 1.83
Visual rating of age-related white matter changes on magnetic resonance imaging: scale comparison, interrater agreement, and correlations with quantitative measurements. Stroke (2003) 1.78
Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett (2000) 1.77
White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease. Evidence for heterogeneity. Brain (1992) 1.77
Familial aggregation in frontotemporal dementia. Neurology (1998) 1.76
Leucoencephalopathy after inhaling "heroin" pyrolysate. Lancet (1982) 1.74
The seven minute screen: a neurocognitive screening test highly sensitive to various types of dementia. J Neurol Neurosurg Psychiatry (2004) 1.73
The effect of APOE genotype on clinical phenotype in Alzheimer disease. Neurology (2006) 1.71
[Acute subdural hematoma following minor head injury]. Ned Tijdschr Geneeskd (1992) 1.69
Hippocampal atrophy in Alzheimer disease: age matters. Neurology (2006) 1.66
Voxel-based morphometry demonstrates reduced grey matter density on brain MRI in patients with diabetic retinopathy. Diabetologia (2006) 1.66
Corpus callosum atrophy as a predictor of age-related cognitive and motor impairment: a 3-year follow-up of the LADIS study cohort. J Neurol Sci (2011) 1.66
A worldwide multicentre comparison of assays for cerebrospinal fluid biomarkers in Alzheimer's disease. Ann Clin Biochem (2009) 1.66
Magnetoencephalographic evaluation of resting-state functional connectivity in Alzheimer's disease. Neuroimage (2006) 1.64
Longitudinal changes of CSF biomarkers in memory clinic patients. Neurology (2007) 1.57
Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology (2011) 1.56
[(123)I]beta-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson's disease. J Neurol Neurosurg Psychiatry (2003) 1.56
Cortico-hippocampal communication by way of parallel parahippocampal-subicular pathways. Hippocampus (2000) 1.55
Functional MR imaging in Alzheimer's disease during memory encoding. AJNR Am J Neuroradiol (2001) 1.54
Circadian rest-activity rhythm disturbances in Alzheimer's disease. Biol Psychiatry (1996) 1.54
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's disease. J Neurol Neurosurg Psychiatry (2005) 1.53
Brain and spinal cord abnormalities in multiple sclerosis. Correlation between MRI parameters, clinical subtypes and symptoms. Brain (1998) 1.52
[123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry (1997) 1.51
Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol (2008) 1.50
X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet (1993) 1.48
Slowing of oscillatory brain activity is a stable characteristic of Parkinson's disease without dementia. Brain (2007) 1.48
Filter run time in CVVH: pre- versus post-dilution and nadroparin versus regional heparin-protamine anticoagulation. Blood Purif (2005) 1.47
Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology (2004) 1.46
The significance of medial temporal lobe atrophy: a postmortem MRI study in the very old. Neurology (2007) 1.46
FMRI of visual encoding: reproducibility of activation. Hum Brain Mapp (2000) 1.46
White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J Neurol Neurosurg Psychiatry (1999) 1.45
Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. Neuroimage (2002) 1.44
A before-after study of multi-resistance and cost of selective decontamination of the digestive tract. Infection (2004) 1.43
Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet (2001) 1.43
Multicenter assessment of CSF-phosphorylated tau for the prediction of conversion of MCI. Neurology (2007) 1.43
A case of progressive aphasia without dementia: "temporal" Pick's disease? J Neurol Neurosurg Psychiatry (1990) 1.42
A case of macrocephaly, hydrocephalus, megacerebellum, white matter abnormalities and Rosenthal fibres. Dev Med Child Neurol (1993) 1.41
Pathophysiologic mechanisms in the development of age-related white matter changes of the brain. Dement Geriatr Cogn Disord (1998) 1.40
Meningeal Gd-DTPA enhancement in multiple sclerosis. AJNR Am J Neuroradiol (1992) 1.40
A systematic review of Instrumental Activities of Daily Living scales in dementia: room for improvement. J Neurol Neurosurg Psychiatry (2009) 1.39
[The immune system and Alzheimer's disease]. Tijdschr Psychiatr (2011) 1.38
Behavioral symptoms in mild cognitive impairment. Neurology (2004) 1.36
Hippocampal shape analysis in Alzheimer's disease: a population-based study. Neuroimage (2007) 1.35
Inter- and intraobserver reproducibility of cerebral atrophy assessment on MRI scans with hemispheric infarcts. Eur Neurol (1996) 1.35
Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology (2007) 1.33
Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell. Ann Neurol (2001) 1.32
Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology (2012) 1.31
Penicillin concentrations in serum and CSF during high-dose intravenous treatment for neurosyphilis. Neurology (1987) 1.30
CSF biomarkers predict rate of cognitive decline in Alzheimer disease. Neurology (2009) 1.30
Intrathecal synthesis of antibodies to HTLV-III in patients without AIDS or AIDS related complex. Br Med J (Clin Res Ed) (1986) 1.30
Patterns of lesion development in multiple sclerosis: longitudinal observations with T1-weighted spin-echo and magnetization transfer MR. AJNR Am J Neuroradiol (1998) 1.30
The clinical benefit of imaging striatal dopamine transporters with [123I]FP-CIT SPET in differentiating patients with presynaptic parkinsonism from those with other forms of parkinsonism. Eur J Nucl Med (2001) 1.28
Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry (2001) 1.26
Diabetes mellitus, hypertension and medial temporal lobe atrophy: the LADIS study. Diabet Med (2007) 1.25
Loss of olfaction in de novo and treated Parkinson's disease: possible implications for early diagnosis. Mov Disord (2001) 1.23
Regional distribution of white matter hyperintensities in vascular dementia, Alzheimer's disease and healthy aging. Dement Geriatr Cogn Disord (2004) 1.22
Chronic manganese intoxication. Arch Neurol (1989) 1.22
A neuromuscular transmission disorder: combined myasthenia gravis and Lambert Eaton syndrome in one patient. J Neurol Neurosurg Psychiatry (1988) 1.22
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med (1998) 1.22
Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? J Neurol Neurosurg Psychiatry (2005) 1.21
Within-subject reproducibility of visual activation patterns with functional magnetic resonance imaging using multislice echo planar imaging. Magn Reson Imaging (1998) 1.21
EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19
Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J Neurol Sci (1994) 1.17
Reliability and sensitivity of visual scales versus volumetry for evaluating white matter hyperintensity progression. Cerebrovasc Dis (2008) 1.17
Progression of cerebral white matter lesions in Alzheimer's disease: a new window for therapy? J Neurol Neurosurg Psychiatry (2005) 1.17
Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology (1999) 1.16
Epidemiology and risk factors of dementia. J Neurol Neurosurg Psychiatry (2005) 1.16
Alterations in brain activation during cholinergic enhancement with rivastigmine in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2002) 1.14
Test-retest analysis with functional MR of the activated area in the human visual cortex. AJNR Am J Neuroradiol (1997) 1.14
Parametric fMRI analysis of visual encoding in the human medial temporal lobe. Hippocampus (1999) 1.13
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume. Diabetologia (2007) 1.11
Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology (1998) 1.11